These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1975196

  • 1. A dose-ranging study to evaluate the beta-adrenoceptor selectivity of single doses of betaxolol.
    Irvine NA, Lipworth BJ, McDevitt DG.
    Br J Clin Pharmacol; 1990 Jul; 30(1):119-26. PubMed ID: 1975196
    [Abstract] [Full Text] [Related]

  • 2. The effects of time and dose on the relative beta 1- and beta 2-adrenoceptor antagonism of betaxolol and atenolol.
    Lipworth BJ, Irvine NA, McDevitt DG.
    Br J Clin Pharmacol; 1991 Feb; 31(2):154-9. PubMed ID: 1675576
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
    Lipworth BJ, Irvine NA, McDevitt DG.
    Eur J Clin Pharmacol; 1991 Feb; 40(2):135-9. PubMed ID: 1676675
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs.
    Pringle TH, Riddell JG, Shanks RG.
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):228-37. PubMed ID: 2441175
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A, Lipworth BJ.
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [Abstract] [Full Text] [Related]

  • 11. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Arnold JM, O'Connor PC, Riddell JG, Harron DW, Shanks RG, McDevitt DG.
    Br J Clin Pharmacol; 1985 May; 19(5):619-30. PubMed ID: 2860915
    [Abstract] [Full Text] [Related]

  • 15. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE, Cragg DJ, Bacon RJ.
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
    Pringle TH, McNeill AJ, Riddell JG, Shanks RG.
    Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS, Tattersfield AE.
    Eur J Clin Pharmacol; 1986 Nov; 29(6):679-83. PubMed ID: 2872056
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.